Despite Serious Headwinds, RBC Likes 3 Tech Stocks for 2016
All the tech indicators continue to look bad. Can investors possible look at technology now? In a new research report from RBC, the answer is yes.
All Work
Lee Jackson
Jefferies Has 4 Top Stocks, Even in a Highly Volatile Market
All these companies deal directly with the U.S. consumer, and increased money in the pocket from lower oil prices is a boon to everybody, regardless of financial status.
Warren Buffett Purchases Highlight Huge Energy Insider Buying: Phillips 66, Summit Midstream, Crestwood Energy and More
After a wild and woolly weak that saw the market plunge to the lows put in last summer, many savvy investors are using the extreme weakness to load the proverbial boat.
Top Cybersecurity Stocks Have Been Crushed: Merrill Lynch Has 3 to Buy Right Now
Cybersecurity is one of the six key themes being highlighted at Merrill Lynch this year. It feels these three companies are best positioned not only for 2016, but for years to come.
Experts Think Half of Oil Industry May Go Bankrupt: 3 Safe Mega-Cap Dividend Energy Stocks to Buy
At least one expert expects half of the U.S. energy industry to go bankrupt this year. But sector disasters bring opportunity — see the housing meltdown in 2007 and 2008.
Jefferies Has 3 Compelling Value Stocks to Buy as Momentum Stocks Get Blasted
These three "compelling value" stocks make good sense for growth investors looking to either move capital around or put some dry powder to work. All are rated Buy at Jefferies.
RBC Lists Top 10 Internet Surprises for 2016
A new research report from the Internet analysts at RBC, offers their top 10 Internet surprises for this year.
Merrill Lynch Has 4 Unloved, High-Dividend Stocks With Big Upside Potential
This January sell-off has the same characteristics of every sell-off. Everything gets sold, regardless of the quality of the investment.
3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential
These companies are well along in clinical trials and some are close to presenting Phase 3 results. Sticking with industry leaders always makes sense in a very volatile sector.
Merrill Lynch Has 6 Crucial Key Investment Themes for 2016
A new research piece from Merrill Lynch Chief Investment Strategist Michael Hartnett outlines six top investment themes thatcould be the trends to watch for 2016.
Does Big Oil Have These 3 Top Energy Companies in Their Sights?
24/7 Wall St. screened the Merrill Lynch research database for companies rated Buy that could also be prime takeover targets.
4 Jefferies Value Stocks to Buy as Market Volatility Jumps in 2016
If there was ever a time to look for value in the markets it’s now. Here are four of this week's value stocks to buy from Jefferies.
3 Super-Regional Banks That Could Beat Earnings Estimates This Week
In a new report, Deutsche Bank is bullish on three super-regional banks, and all three report earnings this week.
3 Old-School Dividend Tech Stocks Could Outperform in Volatile 2016
24/7 Wall St. screened the Merrill Lynch research database and found three stocks that just might be the ticket for investors who have been jolted by the horrible start to the 2016 trading year.
Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start
Jefferies is out with its first group of growth stocks to buy this year, and the list has not only some timely picks, but companies that have been knocked to levels that are providing…
Merrill Lynch Says Apple Slowdown Should Not Effect These Top Chip Stocks to Buy
A new Merrill Lynch research note makes the case that, based on meeting with top corporate executives at the huge Consumer Electronics Show , the gloom and doom mentality running rampant may be way…
3 Biotech Stocks With 2016 Phase 3 Data That Could Have Huge Upside Potential
A new RBC report focuses on top biotech stocks with key data readouts coming in 2016. These three seem to be the farthest along and offer the best chance for approval.
Jefferies Dividend Franchise Picks Stocks to Buy on Sale After Big Market Sell-Off
In a new research note, Jefferies makes the case that earnings could give a lift to the sagging market, and with low expectations, the lift could be solid.
Massive Market Sell-Off Has Energy Insiders Buying: Crestwood Equity Partners, Phillips 66, Summit Midstream Partners and More
One group of investors who welcomed the past week's sell-off were insiders at energy and energy-related companies.
Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.